[nyschp.dop] Re: Daraprim (Out of Office Sept. 21 to Oct.7, 2015)
- From: "NICHOLAS PANTALEO" <NPANTALE@xxxxxxxx>
- To: "nyschp.dop@xxxxxxxxxxxxx" <nyschp.dop@xxxxxxxxxxxxx>
- Date: Tue, 22 Sep 2015 13:20:18 -0400
I will be out of the office until October 7, 2015. Kindly call Louis Cosenza
(#6052) for assistance. Thank you.
N. Pantaleo
"NICHOLAS PANTALEO" <NPANTALE@xxxxxxxx> 09/22/15 13:19 >>>
I will be out of the office until October 7, 2015. Kindly call Louis Cosenza
(#6052) for assistance. Thank you.
N. Pantaleo
"Narayanaswamy, Sudha" <SNarayanaswamy@xxxxxxxxx> 09/21/15 16:08 >>>
In light of recent developments, has your hospital's P&T or ID committee
considered reviewing alternatives to pyrimethamine (Daraprim) for toxoplasmosis?
Sincerely,
Sudha
--
Sudha Narayanaswamy, PharmD, BCPP, CGP
Vice President, Clinical Pharmacy Program
GNYHA Services, Inc. | 555 W. 57th Street, 11th Floor | New York, NY 10019
o: 212-258-5376 | f: 212-541-9032 | E-mail:
snarayanaswamy@xxxxxxxxx<
mailto:snarayanaswamy@xxxxxxxxx>
Website: Http://pharmacy.gnyhaservices.com<
http://pharmacy.gnyhaservices.com/>
CONFIDENTIALITY NOTICE: This electronic, facsimile, or written communication,
including any attachments to it, may contain confidential information or
protected health information subject to privacy regulations such as the Health
Insurance Portability and Accountability Act of 1996 (HIPAA). This transmission
is intended only for the use of the named recipients. If you are not the
intended recipient, or a person responsible for delivering it to the intended
recipient, you are hereby notified that any disclosure, copying, distribution
or use of any of the information contained in this transmission is STRICTLY
PROHIBITED. If you have received this transmission in error, please immediately
notify me by reply e-mail and destroy the original transmission in its entirety
without saving it in any manner.
CONFIDENTIALITY NOTICE: This electronic, facsimile, or written communication,
including any attachments to it, may contain confidential information or
protected health information subject to privacy regulations such as the Health
Insurance Portability and Accountability Act of 1996 (HIPAA). This transmission
is intended only for the use of the named recipients. If you are not the
intended recipient, or a person responsible for delivering it to the intended
recipient, you are hereby notified that any disclosure, copying, distribution
or use of any of the information contained in this transmission is STRICTLY
PROHIBITED. If you have received this transmission in error, please immediately
notify me by reply e-mail and destroy the original transmission in its entirety
without saving it in any manner.
Other related posts:
